Fibrinolytic therapy for COVID-19: a review of case series.

Ji, Hong-Long; Dai, Yuling; Zhao, Runzhen

Ji, Hong-Long; Dai, Yuling; Zhao, Runzhen.

Afiliación

Ji HL; Department of Cellular and Molecular Biology, University of Texas at Tyler Health Science Center, Tyler, TX, USA. james.ji@uthct.edu.
Dai Y; Texas Lung Injury Institute, University of Texas at Tyler Health Science Center, Tyler, TX, USA. james.ji@uthct.edu.
Zhao R; Department of Epidemiology, University of Alabama at Birmingham, Birmingham, AL, USA.

Acta Pharmacol Sin ; 43(8): 2168-2170, 2022 08.

Article en En | MEDLINE | ID: mdl-34893684

Asunto(s)

Tratamiento Farmacológico de COVID-19; Fibrinolíticos/uso terapéutico; Humanos; Terapia Trombolítica

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Tratamiento Farmacológico de COVID-19 Idioma: En Revista: Acta Pharmacol Sin Asunto de la revista: FARMACOLOGIA Año: 2022 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google